|
|
|
|
Drug for Melanoma Shows Promise in Early Trial
An experimental drug for melanoma has successfully shrank tumors that spread to the brain in nine out of 10 patients in part of an international phase I clinical trial.
The drug dabrafen...
|
|
|
|
New Target for Skin Cancer Therapy
Unknown non-coding RNA plays an important role in the biology of melanoma, say researchers.
Most skin cancers are nonmelanomas, arising from cells other than melanocytes (the melan...
|
|
|
|
|
Genomic Landscape of Human Melanoma Tumors
Recent study links genes to melanoma development.
In an article published online May 9 in Nature, the authors provide the first high-resolution view of the genomic landscape of huma...
|
|
|
|
|
|
Skin Cancer Cases on the Rise
Dramatic rise of skin cancer among people under 40 has been reported in a recent study conducted by Mayo Clinic researchers.
"We anticipated we''d find rising rates, as other studie...
|
|
|